Literature DB >> 14581563

Mutations in the vaccinia virus A33R and B5R envelope proteins that enhance release of extracellular virions and eliminate formation of actin-containing microvilli without preventing tyrosine phosphorylation of the A36R protein.

Ehud Katz1, Brian M Ward, Andrea S Weisberg, Bernard Moss.   

Abstract

The spread of vaccinia virus in cell cultures is mediated by virions that adhere to the tips of specialized actin-containing microvilli and also by virions that are released into the medium. The use of a small plaque-forming A36R gene deletion mutant to select spontaneous second-site mutants exhibiting enhanced virus release was described previously. Two types of mutations were found: C-terminal truncations of the A33R envelope protein and a single amino acid substitution of the B5R envelope protein. In the present study, we transferred each type of mutation into a wild-type virus background in order to study their effects in vitro and in vivo. The two new mutants conserved the enhanced virus release properties of the original isolates; the A33R mutant produced considerably more extracellular virus than the B5R mutant. The extracellular virus particles contained the truncated A33R protein in one case and the mutated B5R protein in the other. Remarkably, both mutants failed to form actin tails and specialized microvilli, despite the presence of an intact A36R gene. The synthesis of the A36R protein as well as its physical association with the mutated or wild-type A33R protein was demonstrated. Moreover, the A36R protein was tyrosine phosphorylated, a step mediated by a membrane-associated Src kinase that regulates the nucleation of actin polymerization. The presence of large numbers of adherent virions on the cell surface argued against rapid dissociation as having a key role in preventing actin tail formation. Thus, the A33R and B5R proteins may be more directly involved in the formation or stabilization of actin tails than had been previously thought. When mice were inoculated intranasally, the A33R mutant was highly attenuated and the B5R mutant was mildly attenuated compared to wild-type virus. Enhanced virus release, therefore, did not compensate for the loss of actin tails and specialized microvilli.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14581563      PMCID: PMC254252          DOI: 10.1128/jvi.77.22.12266-12275.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Visualization of intracellular movement of vaccinia virus virions containing a green fluorescent protein-B5R membrane protein chimera.

Authors:  B M Ward; B Moss
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

2.  The envelope protein encoded by the A33R gene is required for formation of actin-containing microvilli and efficient cell-to-cell spread of vaccinia virus.

Authors:  R L Roper; E J Wolffe; A Weisberg; B Moss
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

3.  A complex of N-WASP and WIP integrates signalling cascades that lead to actin polymerization.

Authors:  V Moreau; F Frischknecht; I Reckmann; R Vincentelli; G Rabut; D Stewart; M Way
Journal:  Nat Cell Biol       Date:  2000-07       Impact factor: 28.824

4.  A mutational analysis of the vaccinia virus B5R protein.

Authors:  Elizabeth C Mathew; Christopher M Sanderson; Ruth Hollinshead; Geoffrey L Smith
Journal:  J Gen Virol       Date:  2001-05       Impact factor: 3.891

5.  Actin-based motility of vaccinia virus mimics receptor tyrosine kinase signalling.

Authors:  F Frischknecht; V Moreau; S Röttger; S Gonfloni; I Reckmann; G Superti-Furga; M Way
Journal:  Nature       Date:  1999-10-28       Impact factor: 49.962

6.  The vaccinia virus A33R protein provides a chaperone function for viral membrane localization and tyrosine phosphorylation of the A36R protein.

Authors:  E J Wolffe; A S Weisberg; B Moss
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

7.  The A34R glycoprotein gene is required for induction of specialized actin-containing microvilli and efficient cell-to-cell transmission of vaccinia virus.

Authors:  E J Wolffe; E Katz; A Weisberg; B Moss
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

8.  Interactions between vaccinia virus IEV membrane proteins and their roles in IEV assembly and actin tail formation.

Authors:  S Röttger; F Frischknecht; I Reckmann; G L Smith; M Way
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

9.  Roles of vaccinia virus EEV-specific proteins in intracellular actin tail formation and low pH-induced cell-cell fusion.

Authors:  C M Sanderson; F Frischknecht; M Way; M Hollinshead; G L Smith
Journal:  J Gen Virol       Date:  1998-06       Impact factor: 3.891

10.  Vaccinia virus utilizes microtubules for movement to the cell surface.

Authors:  M Hollinshead; G Rodger; H Van Eijl; M Law; R Hollinshead; D J Vaux; G L Smith
Journal:  J Cell Biol       Date:  2001-07-23       Impact factor: 10.539

View more
  24 in total

1.  The A33-dependent incorporation of B5 into extracellular enveloped vaccinia virions is mediated through an interaction between their lumenal domains.

Authors:  Winnie M Chan; Brian M Ward
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

Review 2.  The non-canonical roles of clathrin and actin in pathogen internalization, egress and spread.

Authors:  Ashley C Humphries; Michael Way
Journal:  Nat Rev Microbiol       Date:  2013-08       Impact factor: 60.633

3.  The structure of the poxvirus A33 protein reveals a dimer of unique C-type lectin-like domains.

Authors:  Hua-Poo Su; Kavita Singh; Apostolos G Gittis; David N Garboczi
Journal:  J Virol       Date:  2009-12-23       Impact factor: 5.103

Review 4.  Poxvirus proteomics and virus-host protein interactions.

Authors:  Kim Van Vliet; Mohamed R Mohamed; Leiliang Zhang; Nancy Yaneth Villa; Steven J Werden; Jia Liu; Grant McFadden
Journal:  Microbiol Mol Biol Rev       Date:  2009-12       Impact factor: 11.056

Review 5.  Rho'ing in and out of cells: viral interactions with Rho GTPase signaling.

Authors:  Céline Van den Broeke; Thary Jacob; Herman W Favoreel
Journal:  Small GTPases       Date:  2014-03-24

6.  Interaction between vaccinia virus extracellular virus envelope A33 and B5 glycoproteins.

Authors:  Beatriz Perdiguero; Rafael Blasco
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

7.  Wiskott-Aldrich syndrome protein is needed for vaccinia virus pathogenesis.

Authors:  Susana Guerra; Miguel Aracil; Raquel Conde; Antonio Bernad; Mariano Esteban
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

8.  Genetically stable and fully effective smallpox vaccine strain constructed from highly attenuated vaccinia LC16m8.

Authors:  Minoru Kidokoro; Masato Tashiro; Hisatoshi Shida
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-07       Impact factor: 11.205

9.  Vaccinia virus A34 glycoprotein determines the protein composition of the extracellular virus envelope.

Authors:  Beatriz Perdiguero; María M Lorenzo; Rafael Blasco
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

Review 10.  Targeted and armed oncolytic poxviruses: a novel multi-mechanistic therapeutic class for cancer.

Authors:  David H Kirn; Steve H Thorne
Journal:  Nat Rev Cancer       Date:  2009-01       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.